Inactivating mutations in the TP53 gene have been reported in more than 50% of pancreatic cancers and commonly result in apoptosis evasion, loss of cell cycle control, and the disabling of DNA damage repair [13]. The gene discussed is TP53; the disease is familial pancreatic carcinoma.